The Food and Drug Administration (FDA) cited Joshua Brumfield in Chatham twice following a Feb. 13 inspection for Monitoring of Marketed Animal Drugs, Feed, and Devices, data from the FDA’s website shows.
The FDA website reports that the company was cited for the following reasons:
- ‘You offered a food-producing animal(s) for interstate commerce that was found to bear or contain a drug residue in an edible tissue above an established safe level, safe concentration, or tolerance.’
- ‘You did not inquire about the medication status of the animal(s) that you purchased and delivered for sale at an auction barn.’
The FDA regularly inspects facilities nationwide to ensure workplaces and products comply with FDA-regulated laws and regulations aimed at protecting public health. Inspection results are released to the public.
The FDA’s website states that the agency oversees the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article is sourced from the U.S. Food and Drug Administration. The source data can be viewed here.
